Mankind Pharma enters exclusive pact to distribute AstraZeneca's anti-asthma drug Symbicort in India
AstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca will retain the intellectual property rights to Symbicort and continue as the marketing authorization holder. Symbicort, a top-selling product globally for AstraZeneca, recorded sales of around $2.4 billion in 2023. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2024 Category: Pharmaceuticals Source Type: news

Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access PITTSBURGH and WOODBURY, Minn., July 31, 2023 -- (Healthcare Sales & Marketing Network) -- Viatris Inc. (NASDAQ: VTRS), a glob... Biopharmaceuticals, Generics, Product Launch Viatris , Kindeva Drug Delivery, Breyna , Symbicort (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 31, 2023 Category: Pharmaceuticals Source Type: news

OTC Budesonide-Formoterol for Asthma Could Save Lives, Money OTC Budesonide-Formoterol for Asthma Could Save Lives, Money
A computer modeling study looked at the use of as-needed budesonide-formoterol compared to inhaled epinephrine for the control of mild asthma.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 4, 2023 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Asthma Treated With Budesonide/Formoterol Via the Elpenhaler Asthma Treated With Budesonide/Formoterol Via the Elpenhaler
Asthma patients who received a fixed-dose combination of budesonide/formoterol via this novel inhaler device were more likely to adhere to treatment and realized quality of life improvements.BMC Pulmonary Medicine (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 29, 2022 Category: Allergy & Immunology Tags: Pulmonary Medicine Journal Article Source Type: news

Adherium gets US FDA 510(k) to connect remote monitoring sensor for Ellipta inhaler users
It follows the clearance for connecting Hailie with AstraZeneca ' s Symbicort inhaler. (Source: mobihealthnews)
Source: mobihealthnews - July 28, 2022 Category: Information Technology Source Type: news

First Generic of Symbicort Receives FDA Approval
The generic metered - dose inhaler containing budesonide and formoterol fumarate dihydrate is indicated for treatment of asthma and COPD (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 13, 2022 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Pediatrics, Pharmacy, Pulmonology, FDA Approvals, Source Type: news

First Generic of Symbicort Receives FDA Approval
TUESDAY, April 12, 2022 -- The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2022 Category: Pharmaceuticals Source Type: news

Viatris receives FDA approval for generic asthma drug
The approval is for a product called Breyna, a generic version of AstraZeneca ’s Symbicort, an inhaled medication that treats asthma and chronic obstructive pulmonary disease. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 16, 2022 Category: American Health Authors: Jordyn Hronec Source Type: news

FDA Approves Generic Symbicort for Asthma, COPD FDA Approves Generic Symbicort for Asthma, COPD
The approval is for the first generic of the most commonly prescribed complex drug-device combination products to treat asthma and COPD.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 16, 2022 Category: Allergy & Immunology Tags: Pulmonary Medicine News Alert Source Type: news

First Generic OK'd for Popular Asthma, COPD Inhaler
(MedPage Today) -- The first generic version of Symbicort -- a metered-dose inhaler that combines the corticosteroid budesonide with the long-acting bronchodilator formoterol -- has been approved for asthma and chronic obstructive pulmonary... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 15, 2022 Category: Allergy & Immunology Source Type: news

FDA approves first generic of Symbicort to treat asthma and COPD
Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma in patients six years of age and older; and the maintenance treatment of airflow obstruction and reducing exacerbations for patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. (Source: World Pharma News)
Source: World Pharma News - March 15, 2022 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Asthma Rescue With Budesonide-Formoterol Cuts Short-Term Flare Risk Asthma Rescue With Budesonide-Formoterol Cuts Short-Term Flare Risk
Patients with mild asthma who aren ' t adhering to maintenance therapy have a lower short-term risk of severe exacerbations after a single day of increased use of as-needed budesonide-formoterol, according to a post-hoc analysis from the SYGMA 1 study.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 13, 2020 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Breztri Aerosphere (Budesonide, Glycopyrrolate, and Formoterol Fumarate Inhalation Aerosol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 3, 2020 Category: Drugs & Pharmacology Source Type: news

Breztri Aerosphere (Budesonide, Glycopyrrolate, and Formoterol Fumarate Inhalation Aerosol) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 29, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD
24 July 2020 -- AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). The approval by the US... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 24, 2020 Category: Drugs & Pharmacology Source Type: news